Advanced Malignancies, Non-small Cell Lung Cancer
1 clinical trials · Condition
◉ Watch Advanced Malignancies, Non-small Cell Lung Cancer
| Record | Firm | Date |
|---|---|---|
| A Study of MGCD265 Given With Erlotinib or Docetaxel in Subjects With Advanced Malignancies or Non-Small Cell Lung Cancer (NCT00975767) | Mirati Therapeutics Inc. | 2009-08-01 |
Track Advanced Malignancies, Non-small Cell Lung Cancer automatically
Every clearance here is in the API, with alerts when new ones post.